Norra Kwong, MD | UniHealth

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plans that list them

2 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kwong’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

2 of 2 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health Sutter Advantage +More (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A110578 · Current

Licensed to practise in California · since 2010 · expires 2028-01-31 · University of California, Los Angeles School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025

See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Peninsula Medical Center

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.139	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.242	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.21 (0.27 to 2.15) · 1,258 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.81 (0.51 to 1.1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	155.44 (112.67 to 198.21) · 90 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.5 · 32 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 82 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10 · 188 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9 · 473 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.8 · 342 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.4 · 485 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.9 · 3,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.2 (0 to 0.4) · 6,904 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.21 (0.02 to 0.4) · 7,052 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.41 (1.43 to 5.39) · 1,695 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.72 (0.17 to 3.28) · 665 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.66 to 3.56) · 1,545 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.1 (1.3 to 12.9) · 670 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.96 (2.63 to 9.29) · 653 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.61 (0.15 to 3.08) · 418 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.14 (0 to 0.78) · 5,539 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.7 · 192 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.215	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.263	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.74	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 300 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19 · 702 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	1.2 · 207 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-13.6 · 531 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	24.3 · 343 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.1 · 449 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	4.5 (2.8 to 7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	9.6 (6.7 to 13.7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.7 · 189 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	11 · 45 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.6 · 117 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13 (9.7 to 17.2) · 584 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.2) · 764 cases	No different	Jan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Sort by

Patient survey stars by topic at Peninsula Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at Peninsula Medical Center

Room was "always" clean	76%
Nurses "always" communicated well	81%
Doctors "always" communicated well	80%
Staff "always" explained	58%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	79%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	72%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	54%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$348,854

Medicare paid this office $348,854 for 660 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Injection, denosumab, 1 mg	90	$184,580	None
Return visit (30+ min)	469	$78,317	$109
New patient visit (60+ min)	98	$19,083	$195
Short return visit (20+ min)	159	$15,369	$80
Long return visit (40+ min)	50	$8,318	$157

See all 11 services

Sort by

Every Original Medicare service billed

Injection, denosumab, 1 mg	90	$184,580	None
Return visit (30+ min)	469	$78,317	$109
New patient visit (60+ min)	98	$19,083	$195
Short return visit (20+ min)	159	$15,369	$80
Long return visit (40+ min)	50	$8,318	$157
New patient visit (45+ min)	47	$6,942	$148
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment	25	$4,880	$163
Fine needle aspiration biopsy using ultrasound guidance, first growth	28	$4,494	$128
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	251	$4,296	$15
Injection of drug or substance under skin or into muscle	97	$2,529	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	36	$1,126	$30

Who their Medicare patients are

660 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 14% · Women 74% · Also on Medicaid 6% · Health risk score 0.90. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 57% · Diabetes 30% · Coronary heart disease 22% · Chronic kidney disease 20% · Cancer 17% · Atrial fibrillation 13% · Depression 11% · Heart failure 7% · COPD 6% · Stroke 5% · Dementia 3%.

The office billed $1,000,584, Medicare allowed $454,816 and paid $348,854; for 12,802 services of 20 kinds; $202,550 of it was for drugs given in the office and $146,304 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	660	12,802	76	0.90	$1,000,584	$348,854
2023	519	9,659	76	0.90	$746,094	$258,005
2022	497	13,854	75	0.95	$795,488	$268,869
2021	516	9,129	75	0.93	$652,335	$225,213
2020	411	5,123	75	1.02	$424,457	$138,494
2019	427	5,897	75	1.10	$435,975	$125,952
2018	354	4,201	74	1.13	$364,130	$97,489
2017	240	1,834	74	1.00	$285,449	$75,667
2016	58	187	73	0.74	$31,122	$9,186
2015	21	29	80	2.64	$10,812	$2,409
2014	260	336	78	2.40	$111,840	$25,596
2013	25	39	80	1.70	$12,936	$2,903

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Sort by

Original Medicare services billed in 2023

Injection, denosumab, 1 mg	76	$145,304	None
Return visit (30+ min)	409	$67,046	$106
New patient visit (60+ min)	49	$9,139	$187
Short return visit (20+ min)	93	$9,028	$79
Long return visit (40+ min)	52	$8,946	$160
Fine needle aspiration biopsy using ultrasound guidance, first growth	21	$2,816	$134
New patient visit (45+ min)	17	$2,246	$132
Injection of drug or substance under skin or into muscle	82	$2,049	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	28	$988	$30

2022: 8 services

Sort by

Original Medicare services billed in 2022

Injection, denosumab, 1 mg	70	$121,550	None
Return visit (30+ min)	368	$61,042	$110
Long return visit (40+ min)	87	$14,611	$146
Short return visit (20+ min)	108	$9,606	$79
New patient visit (60+ min)	45	$8,521	$189
Fine needle aspiration biopsy using ultrasound guidance, first growth	27	$3,990	$138
Injection of drug or substance under skin or into muscle	76	$2,425	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	21	$963	$32

2021: 11 services

Sort by

Original Medicare services billed in 2021

Injection, denosumab, 1 mg	65	$106,043	None
Return visit (30+ min)	314	$48,618	$111
New patient visit (60+ min)	89	$16,876	$190
Long return visit (40+ min)	75	$12,700	$163
Short return visit (20+ min)	116	$10,670	$77
New patient visit (45+ min)	41	$6,424	$157
Fine needle aspiration biopsy using ultrasound guidance, first growth	29	$4,043	$139
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment	11	$1,996	$166
Injection of drug or substance under skin or into muscle	75	$1,823	$14
Telephone medical discussion with physician, 21-30 minutes	13	$1,184	$91
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	11	$459	$33

2020: 11 services

Sort by

Original Medicare services billed in 2020

Injection, denosumab, 1 mg	46	$66,046	None
Return visit (30+ min)	173	$20,775	$94
Short return visit (20+ min)	161	$13,207	$63
New patient visit (45+ min)	64	$8,368	$131
New patient visit (60+ min)	39	$6,175	$158
Telephone medical discussion with physician, 11-20 minutes	61	$5,659	$69
Telephone medical discussion with physician, 21-30 minutes	37	$4,644	$103
Long return visit (40+ min)	33	$4,613	$128
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment	12	$2,918	$162
Fine needle aspiration biopsy using ultrasound guidance, first growth	17	$2,352	$124
Injection of drug or substance under skin or into muscle	49	$1,055	$14

2019: 9 services

Sort by

Original Medicare services billed in 2019

Injection, denosumab, 1 mg	37	$47,739	None
Return visit (30+ min)	194	$24,671	$96
Short return visit (20+ min)	178	$16,665	$66
New patient visit (60+ min)	57	$10,116	$177
New patient visit (45+ min)	70	$9,726	$139
Long return visit (40+ min)	75	$9,383	$117
Fine needle aspiration biopsy using ultrasound guidance, first growth	30	$4,457	$124
Injection of drug or substance under skin or into muscle	42	$1,094	$16
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	13	$612	$32

2018: 10 services

Sort by

Original Medicare services billed in 2018

Injection, denosumab, 1 mg	23	$32,198	None
Return visit (30+ min)	141	$18,454	$93
Short return visit (20+ min)	144	$12,749	$63
New patient visit (45+ min)	90	$11,725	$130
New patient visit (60+ min)	41	$7,512	$183
Long return visit (40+ min)	42	$5,057	$120
Fine needle aspiration using imaging guidance	24	$4,318	$139
Ultrasonic guidance for needle placement	26	$1,758	$55
New patient visit (30+ min)	17	$1,709	$101
Injection of drug or substance under skin or into muscle	29	$1,061	$20

2017: 10 services

Sort by

Original Medicare services billed in 2017

Injection, denosumab, 1 mg	15	$16,711	None
Return visit (30+ min)	99	$13,238	$93
New patient visit (60+ min)	61	$10,921	$179
New patient visit (45+ min)	76	$10,618	$140
Short return visit (20+ min)	78	$7,261	$67
Fine needle aspiration using imaging guidance	32	$6,517	$139
Long return visit (40+ min)	44	$5,463	$124
Ultrasonic guidance for needle placement	29	$2,111	$57
New patient visit (30+ min)	17	$1,714	$101
Injection of drug or substance under skin or into muscle	20	$697	$25

2016: 3 services

Sort by

Original Medicare services billed in 2016

New patient visit (45+ min)	19	$2,688	$141
Long return visit (40+ min)	12	$1,616	$135
Return visit (30+ min)	15	$1,434	$96

2014: 6 services

Sort by

Original Medicare services billed in 2014

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	117	$8,761	$58
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	37	$4,178	$110
Initial hospital observation care per day, typically 50 minutes	32	$3,331	$104
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	28	$2,742	$83
Hospital discharge day management, more than 30 minutes	24	$2,062	$86
Follow-up observation care per day, typically 25 minutes	13	$813	$58

Medicaid work

$686 in 2023

Medicaid paid $686 for 24 billed services this clinician did in 2023, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2023

Return visit (30+ min)	24	$686

Sort by

Medicaid work by year

2023	24	1	12	$686

Drugs they prescribed that Part D paid

$1,453,112

Pharmacies billed $1,453,112 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 3,152) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

1,598 generic and 1,429 brand-name prescriptions · $1,453,112 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Trulicity	244	$403,083	$1,652
Ozempic	200	$297,625	$1,488
Jardiance	199	$274,900	$1,381
Mounjaro	88	$155,441	$1,766
Tradjenta	34	$45,535	$1,339

See all 44 drugs

Sort by

Every Part D drug this clinician prescribed

Trulicity	244	$403,083	$1,652
Ozempic	200	$297,625	$1,488
Jardiance	199	$274,900	$1,381
Mounjaro	88	$155,441	$1,766
Tradjenta	34	$45,535	$1,339
Tymlos	13	$35,413	$2,724
Januvia	15	$18,377	$1,225
Farxiga	12	$14,934	$1,245
Synthroid	155	$14,634	$94
Tresiba Flextouch U-100	14	$13,856	$990
Humalog Kwikpen U-100	40	$10,790	$270
Basaglar Kwikpen U-100	19	$9,607	$506
Lantus Solostar	52	$7,917	$152
Invokana	12	$7,090	$591
Humulin R U-500 Kwikpen	15	$6,721	$448
Levothyroxine	410	$6,193	$15
Cinacalcet	26	$5,750	$221
Nano 2nd Gen Pen Needle	38	$5,105	$134
Alendronate	453	$3,747	$8
Ultra-Fine Mini Pen Needle	19	$2,708	$143
Metformin Hcl Er	178	$2,492	$14
Risedronate	30	$2,139	$71
Nateglinide	22	$2,067	$94
Novolog Flexpen	12	$1,958	$163
Ultra-Fine Nano Pen Needle	14	$1,826	$130
Insulin Aspart Flexpen	11	$1,507	$137
Glipizide	70	$1,448	$21
Metformin	130	$1,382	$11
Acarbose	13	$1,115	$86
Glipizide Er	57	$999	$18
Levoxyl	15	$955	$64
Insulin	11	$888	$81
Methimazole	75	$795	$11
Hydrocortisone	19	$745	$39
Ultra-Fine Short Pen Needle	11	$728	$66
Atorvastatin	37	$555	$15
Rosuvastatin	23	$340	$15
Simvastatin	24	$313	$13
Spironolactone	11	$140	$13
Prednisone	11	$113	$10
Lisinopril	17	$75	$4
Glimepiride	11	$74	$7
Hydrochlorothiazide	12	$66	$5
Dexamethasone	21	$29	$1

Year by year

Sort by

Part D prescribing by year

2024	3,152	488	0% (0)	45%	$1,453,112
2023	2,722	415	0% (0)	47%	$1,583,422
2022	2,686	396	0% (0)	47%	$1,405,255
2021	2,273	366	0% (0)	46%	$996,724
2020	1,917	292	0% (0)	48%	$826,288
2019	1,604	259	0% (0)	50%	$709,700
2018	1,162	219	0% (0)	49%	$441,334
2017	864	232	0% (0)	42%	$215,001
2016	696	260	0% (0)	28%	$178,969
2015	179	85	0% (0)	32%	$52,679
2014	125	34	None	None	$13,581
2013	96	22	0% (0)	34%	$14,665

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 40 drugs

Sort by

Part D drugs prescribed in 2023

Trulicity	329	$610,545	$1,856
Jardiance	147	$202,043	$1,374
Ozempic	85	$143,814	$1,692
Forteo	27	$124,441	$4,609
Mounjaro	46	$79,651	$1,732
Tymlos	23	$64,852	$2,820
Tradjenta	36	$49,391	$1,372
Lantus Solostar	54	$43,108	$798
Humalog Kwikpen U-100	37	$35,753	$966
Tresiba Flextouch U-100	27	$24,468	$906
Farxiga	11	$17,875	$1,625
Synthroid	132	$15,137	$115
Tresiba Flextouch U-200	11	$14,403	$1,309
Basaglar Kwikpen U-100	28	$12,569	$449
Novolog Flexpen	13	$7,747	$596
Invokana	11	$6,499	$591
Levothyroxine	342	$4,849	$14
Ultra-Fine Mini Pen Needle	28	$3,844	$137
Risedronate	22	$3,761	$171
Nano 2nd Gen Pen Needle	34	$3,738	$110
Alendronate	363	$3,710	$10
Metformin Hcl Er	135	$2,971	$22
Insulin Glargine-Yfgn	13	$2,912	$224
Nateglinide	15	$2,492	$166
Metformin	125	$1,783	$14
Glipizide Er	64	$1,776	$28
Cinacalcet	15	$1,445	$96
Ultra-Fine Short Pen Needle	16	$1,345	$84
Hydrocortisone	23	$1,243	$54
Insulin	11	$948	$86
Glipizide	46	$941	$20
Methimazole	73	$927	$13
Atorvastatin	31	$473	$15
Rosuvastatin	15	$421	$28
Simvastatin	25	$318	$13
Levoxyl	11	$290	$26
Glimepiride	14	$133	$10
Lisinopril	13	$114	$9
Hydrochlorothiazide	13	$42	$3
Dexamethasone	11	$9	$1

2022: 41 drugs

Sort by

Part D drugs prescribed in 2022

Trulicity	357	$573,924	$1,608
Jardiance	148	$196,590	$1,328
Forteo	31	$127,999	$4,129
Ozempic	58	$92,749	$1,599
Lantus Solostar	81	$65,595	$810
Tymlos	20	$52,008	$2,600
Tradjenta	30	$44,763	$1,492
Humalog Kwikpen U-100	33	$38,792	$1,176
Teriparatide	13	$34,427	$2,648
Basaglar Kwikpen U-100	28	$13,027	$465
Synthroid	109	$11,569	$106
Januvia	15	$10,983	$732
Novolog Flexpen	11	$10,557	$960
Tresiba Flextouch U-100	16	$9,108	$569
Invokana	12	$6,753	$563
Levothyroxine	303	$5,850	$19
Tirosint	12	$3,761	$313
Nano 2nd Gen Pen Needle	38	$3,540	$93
Metformin	143	$3,501	$24
Alendronate	391	$3,485	$9
Insulin Lispro Kwikpen U-100	14	$2,941	$210
Ultra-Fine Mini Pen Needle	19	$2,068	$109
Metformin Hcl Er	116	$2,042	$18
Hydrocortisone	26	$2,042	$79
Fosamax	11	$1,888	$172
Cinacalcet	16	$1,806	$113
Risedronate	16	$1,789	$112
Glipizide Er	62	$1,516	$24
Methimazole	81	$1,187	$15
Ultra-Fine Short Pen Needle	15	$1,168	$78
Nateglinide	14	$1,088	$78
Acarbose	20	$1,023	$51
Rosuvastatin	13	$632	$49
Glipizide	35	$528	$15
Atorvastatin	29	$359	$12
Glipizide Xl	15	$219	$15
Simvastatin	16	$212	$13
Levoxyl	21	$211	$10
Amlodipine Besylate	17	$143	$8
Losartan	11	$98	$9
Hydrochlorothiazide	30	$63	$2

2021: 38 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	267	$398,369	$1,492
Jardiance	120	$142,894	$1,191
Lantus Solostar	91	$61,129	$672
Ozempic	44	$60,890	$1,384
Tradjenta	36	$43,587	$1,211
Humalog Kwikpen U-100	28	$29,318	$1,047
Novolog Flexpen	28	$27,289	$975
Januvia	25	$24,929	$997
Humalog Mix 75-25 Kwikpen	14	$20,112	$1,437
Basaglar Kwikpen U-100	28	$14,867	$531
Tresiba Flextouch U-200	12	$14,769	$1,231
Victoza 3-Pak	12	$13,207	$1,101
Humulin R U-500 Kwikpen	11	$10,098	$918
Synthroid	96	$9,669	$101
Insulin Lispro Kwikpen U-100	24	$7,559	$315
Invokana	12	$6,413	$534
Levothyroxine	238	$6,023	$25
Cinacalcet	13	$4,316	$332
Alendronate	341	$3,197	$9
Tirosint	13	$3,043	$234
Nano 2nd Gen Pen Needle	31	$2,923	$94
Ultra-Fine Mini Pen Needle	26	$2,607	$100
Risedronate	19	$1,874	$99
Hydrocortisone	21	$1,704	$81
Metformin Hcl Er	95	$1,666	$18
Metformin	112	$1,211	$11
Rosuvastatin	14	$1,208	$86
Methimazole	74	$1,202	$16
Armour Thyroid	25	$990	$40
Glipizide Er	41	$956	$23
Glipizide	30	$567	$19
Nateglinide	12	$470	$39
Levoxyl	26	$423	$16
Atorvastatin	33	$368	$11
Amlodipine Besylate	14	$278	$20
Glimepiride	19	$272	$14
Simvastatin	12	$134	$11
Hydrochlorothiazide	19	$117	$6

2020: 32 drugs

Sort by

Part D drugs prescribed in 2020

Trulicity	192	$253,722	$1,321
Jardiance	80	$101,433	$1,268
Lantus Solostar	112	$64,366	$575
Tradjenta	53	$56,472	$1,066
Ozempic	30	$42,400	$1,413
Victoza 3-Pak	20	$38,307	$1,915
Humalog Kwikpen U-100	34	$31,030	$913
Januvia	31	$28,911	$933
Novolog Flexpen	27	$28,245	$1,046
Humalog Mix 75-25 Kwikpen	22	$24,869	$1,130
Basaglar Kwikpen U-100	23	$11,119	$483
Insulin Lispro Kwikpen U-100	19	$9,870	$519
Synthroid	74	$6,968	$94
Levothyroxine	204	$5,544	$27
Ultra-Fine Nano Pen Needle	39	$4,050	$104
Ultra-Fine Mini Pen Needle	29	$2,422	$84
Metformin Hcl Er	98	$2,255	$23
Risedronate	16	$2,108	$132
Alendronate	180	$1,760	$10
Metformin	108	$1,183	$11
Nateglinide	13	$981	$75
Nano 2nd Gen Pen Needle	13	$900	$69
Methimazole	53	$894	$17
Glipizide	39	$740	$19
Hydrocortisone	14	$697	$50
Glipizide Er	40	$655	$16
Rosuvastatin	12	$545	$45
Glimepiride	28	$319	$11
Atorvastatin	23	$314	$14
Amlodipine Besylate	14	$214	$15
Simvastatin	15	$129	$9
Hydrochlorothiazide	13	$107	$8

2019: 33 drugs

Sort by

Part D drugs prescribed in 2019

Trulicity	153	$178,070	$1,164
Jardiance	68	$71,774	$1,055
Lantus Solostar	84	$58,199	$693
Tradjenta	46	$47,281	$1,028
Humalog Kwikpen U-100	44	$45,771	$1,040
Humalog Mix 75-25 Kwikpen	31	$35,535	$1,146
Januvia	41	$33,876	$826
Victoza 3-Pak	19	$32,153	$1,692
Victoza 2-Pak	20	$18,464	$923
Novolog Flexpen	14	$18,092	$1,292
Ozempic	24	$17,800	$742
Levemir Flextouch	14	$14,681	$1,049
Basaglar Kwikpen U-100	20	$9,934	$497
Toujeo Solostar	12	$8,294	$691
Synthroid	59	$5,955	$101
Levothyroxine	158	$3,849	$24
Ultra-Fine Nano Pen Needle	38	$3,560	$94
Ultra-Fine Mini Pen Needle	38	$2,763	$73
Nateglinide	15	$1,350	$90
Metformin Hcl Er	52	$1,212	$23
Alendronate	137	$1,179	$9
Metformin	84	$1,031	$12
Hydrocortisone	22	$947	$43
Repaglinide	13	$784	$60
Glipizide Er	17	$722	$42
Atorvastatin	28	$586	$21
Methimazole	43	$561	$13
Glipizide	42	$523	$12
Glimepiride	18	$272	$15
Amlodipine Besylate	18	$154	$9
Lisinopril	13	$146	$11
Spironolactone	18	$144	$8
Simvastatin	12	$100	$8

2018: 27 drugs

Sort by

Part D drugs prescribed in 2018

Trulicity	101	$107,832	$1,068
Forteo	15	$50,651	$3,377
Tradjenta	49	$44,633	$911
Lantus Solostar	65	$35,752	$550
Jardiance	36	$27,853	$774
Victoza 3-Pak	20	$18,764	$938
Humalog Kwikpen U-100	16	$16,675	$1,042
Januvia	23	$16,245	$706
Victoza 2-Pak	16	$13,864	$867
Novolog Flexpen	14	$10,504	$750
Lantus	11	$9,297	$845
Basaglar Kwikpen U-100	18	$8,211	$456
Levothyroxine	137	$3,548	$26
Synthroid	44	$3,311	$75
Ultra-Fine Nano Pen Needle	35	$2,267	$65
Repaglinide	16	$1,518	$95
Ultra-Fine Mini Pen Needle	23	$1,053	$46
Alendronate	119	$980	$8
Hydrocortisone	14	$769	$55
Atorvastatin	34	$669	$20
Metformin Hcl Er	45	$575	$13
Metformin	45	$482	$11
Glipizide Er	12	$473	$39
Glipizide	17	$296	$17
Methimazole	23	$277	$12
Lisinopril	13	$194	$15
Glimepiride	27	$163	$6

2017: 20 drugs

Sort by

Part D drugs prescribed in 2017

Forteo	12	$35,198	$2,933
Trulicity	41	$31,496	$768
Tradjenta	27	$19,243	$713
Lantus Solostar	37	$18,164	$491
Januvia	15	$12,575	$838
Humalog Kwikpen U-100	17	$10,634	$626
Lantus	21	$8,610	$410
Novolog Flexpen	14	$7,226	$516
Levothyroxine	203	$5,943	$29
Glucagon Emergency Kit	14	$4,201	$300
Synthroid	30	$2,491	$83
Humalog	11	$2,335	$212
Humulin N Kwikpen	15	$2,208	$147
Ultra-Fine Nano Pen Needle	24	$1,781	$74
Hydrocortisone	17	$1,094	$64
Repaglinide	19	$953	$50
Alendronate	104	$696	$7
Atorvastatin	27	$542	$20
Metformin Hcl Er	24	$240	$10
Metformin	17	$179	$11

2016: 13 drugs

Sort by

Part D drugs prescribed in 2016

Levothyroxine	341	$12,145	$36
Lantus	13	$8,988	$691
Glucagon Emergency Kit	15	$4,530	$302
Synthroid	41	$4,418	$108
Humalog	11	$1,969	$179
Humalog Kwikpen U-100	15	$1,929	$129
Humulin N Kwikpen	13	$1,795	$138
Humulin N	14	$1,222	$87
Hydrocortisone	19	$1,195	$63
Methimazole	42	$1,042	$25
Bd Ultra-Fine Pen Needle	16	$628	$39
Alendronate	26	$336	$13
Insulin	12	$209	$17

2015: 4 drugs

Sort by

Part D drugs prescribed in 2015

Lantus Solostar	11	$5,701	$518
Levothyroxine	66	$2,061	$31
Synthroid	11	$1,017	$92
Prednisone	13	$125	$10

2014: 4 drugs

Sort by

Part D drugs prescribed in 2014

Synthroid	15	$1,130	$75
Levothyroxine	12	$193	$16
Prednisone	17	$122	$7
Simvastatin	12	$115	$10

Money from drug and device companies

$32 in 2019

A payment is not proof that care is biased.

Sort by

Payments by company

Novo Nordisk	Saxenda	$32	1 payment Education for Saxenda · 2019-02-14 · $32

See the published payment

Sort by

Every published payment

Novo Nordisk	Education · 2019-02-14	Saxenda	$32

Professional record

NPI: 1689840415
Licence: CA A110578California A110578: Current · expires 2028-01-31
Trained: University of California, Geffen School of Medicine, 2008
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2008-05-01
NPI last updated: 2020-05-29
NPI record certified: 2020-05-29

This is when the NPI record was last certified, not a medical board exam.